Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Vivos Therapeutics (VVOS) Non-Current Receivables (2019 - 2021)

Historic Non-Current Receivables for Vivos Therapeutics (VVOS) over the last 3 years, with Q3 2021 value amounting to $842290.0.

  • Vivos Therapeutics' Non-Current Receivables changed N/A to $842290.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $842290.0, marking a year-over-year change of. This contributed to the annual value of $811000.0 for FY2020, which is 330.41% up from last year.
  • According to the latest figures from Q3 2021, Vivos Therapeutics' Non-Current Receivables is $842290.0.
  • Over the past 5 years, Vivos Therapeutics' Non-Current Receivables peaked at $846214.0 during Q2 2021, and registered a low of $785061.0 during Q4 2019.
  • In the last 3 years, Vivos Therapeutics' Non-Current Receivables had a median value of $816584.0 in 2021 and averaged $820229.8.
  • Examining YoY changes over the last 5 years, Vivos Therapeutics' Non-Current Receivables showed a top increase of 330.41% in 2020 and a maximum decrease of 330.41% in 2020.
  • Quarter analysis of 3 years shows Vivos Therapeutics' Non-Current Receivables stood at $785061.0 in 2019, then increased by 3.3% to $811000.0 in 2020, then rose by 3.86% to $842290.0 in 2021.
  • Its Non-Current Receivables was $842290.0 in Q3 2021, compared to $846214.0 in Q2 2021 and $816584.0 in Q1 2021.